CONSOLIDATED STATEMENTS OF OPERATIONS (Parenthetical) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Total share-based compensation expense	$ 25,371	$ 39,734
Research and development
Total share-based compensation expense	8,048	12,888
Selling, general and administrative
Total share-based compensation expense	16,966	19,848
Restructuring and related expenses
Total share-based compensation expense	$ 357	$ 6,998